Fig. 5.
Fig. 5. Days to engraftment, for all treatment groups, for platelets ≥20 × 109/L (A) and for ANC ≥0.5 × 109/L (B). Censored patients have been included and the median, 25th, and 75th percentiles and range are shown. Section I includes those treatment groups in which 3 PBPC harvests were infused and section II includes those in which only 1 harvest was infused. Data from 185 patients have been included; this does not include 1 patient who withdrew from the study before PBPC infusion and treatment group H, which only enrolled 3 patients.

Days to engraftment, for all treatment groups, for platelets ≥20 × 109/L (A) and for ANC ≥0.5 × 109/L (B). Censored patients have been included and the median, 25th, and 75th percentiles and range are shown. Section I includes those treatment groups in which 3 PBPC harvests were infused and section II includes those in which only 1 harvest was infused. Data from 185 patients have been included; this does not include 1 patient who withdrew from the study before PBPC infusion and treatment group H, which only enrolled 3 patients.

Close Modal

or Create an Account

Close Modal
Close Modal